Géric Maura

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Journal of the American Geriatrics Society

Drug safety

Pharmacoepidemiology and drug safety

Scientific reports

Caisse nationale de l'Assurance maladie (Cnam, French Statutory Health Insurance Fund)

Université de Bordeaux Ecole Doctorale Sociétés Politique Santé Publique (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Caisse nationale de l'Assurance maladie (Cnam, French Statutory Health Insurance Fund) Jan 21 2013

France

Expert Santé Publique; PharmD, PhD, Pharmacoepidemiologist :: Department of Studies in Public Health

Education History

Université de Bordeaux Ecole Doctorale Sociétés Politique Santé Publique - Nov 15 2018

France

PHD

Université de Bordeaux

France

MSC

Publications

Máté Szilcz, Jonas W Wastesson, Amaia Calderon-Larranaga, Daniel Prieto Alhambra, Pierre-Olivier Blotière, Géric Maura, Kristina Johnell
Reply to: Peptic ulcers with ChEIs, NSAIDs. Journal of the American Geriatrics Society (2024)
Géric Maura, Pierre-Olivier Blotière, Jonas W Wastesson, Kristina Johnell
Spousal bereavement and four-year trajectories of medication use: A nationwide register-based study in Swedish older adults. Journal of the American Geriatrics Society (2024)
Géric Maura, Pierre-Olivier Blotière, Jonas W Wastesson, Kristina Johnell
Spousal bereavement and four-year trajectories of medication use: A nationwide register-based study in Swedish older adults. Journal of the American Geriatrics Society 72 (7) (2024)
Máté Szilcz, Jonas W Wastesson, Amaia Calderon-Larranaga, Daniel Prieto Alhambra, Pierre-Olivier Blotière, Géric Maura, Kristina Johnell
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled study. Journal of the American Geriatrics Society (2023)
Pierre-Olivier Blotière, Christine Damase-Michel, Alain Weill, Géric Maura
Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems. Drug safety 44 (12) (2021)
Géric Maura, Marc Bardou, Cécile Billionnet, Alain Weill, Jérôme Drouin, Anke Neumann
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study. Scientific reports 10 (1) (2020)
Géric Maura, Cécile Billionnet, Jérôme Drouin, Alain Weill, Anke Neumann, Antoine Pariente
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016. BMJ open 9 (4) (2019)
Géric Maura, Cécile Billionnet, Joël Coste, Alain Weill, Anke Neumann, Antoine Pariente
Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis. Drug safety 41 (9) (2018)
Géric Maura, Antoine Pariente, François Alla, Cécile Billionnet
Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study. Pharmacoepidemiology and drug safety 26 (11) (2017)
Cécile Billionnet, François Alla, Éric Bérigaud, Antoine Pariente, Géric Maura
Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases. Pharmacoepidemiology and drug safety 26 (5) (2017)
Géric Maura, Cécile Billionnet, François Alla, Joshua J Gagne, Antoine Pariente
Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases. Pharmacotherapy 38 (1) (2017)

Géric Maura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Géric Maura